The U.S. Food and Drug Administration (FDA) approved Impulse Dynamics’ Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure to restore a normal timing...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.
-
-
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 annual meeting March 16-18,...
-
March 14, 2019 — The U.S.
-
Robert Klempfner, M.D., director of the Cardiovascular Prevention Institute,...
News | Heart Failure | March 29, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes...
![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](https://www.dicardiology.com/sites/daic/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=zkKfDjIR)
News | Heart Failure | March 27, 2019
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/...
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that has developed a toilet-seat based cardiovascular monitoring system. Image courtesy of A. Sue Weisler/RIT.
News | Heart Failure | March 26, 2019
March 26, 2019 — A toilet seat-based...
News | Ventricular Assist Devices (VAD) | March 22, 2019
March 22, 2019 — Severely ill patients with advanced...
Technology | Heart Failure | March 21, 2019
March 21, 2019 — The U.S. Food and Drug Administration (FDA) approved Impulse Dynamics’ Optimizer Smart system for...
The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.
Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the...
Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 15, 2019
March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor...
Feature | Heart Valve Technology | March 14, 2019 | Jeff Zagoudis, Associate Editor
March 14, 2019 — The U.S. Food and Drug Administration (FDA) approved the MitraClip...
William T. Abraham, M.D., in an interview with DAIC Editor Dave Fornell at TCT 2016.
News | Heart Failure | March 12, 2019
March 12, 2019 — V-Wave Ltd. announced that renowned heart failure cardiologist...
News | Stem Cell Therapies | March 04, 2019
March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding...
Sponsored Content | Videos | Heart Failure | February 13, 2019
